Improving the core resilience of real-world hypergraphs

被引:0
作者
Do, Manh Tuan [1 ]
Shin, Kijung [1 ,2 ]
机构
[1] Korea Adv Inst Sci & Technol, Kim Jaechul Grad Sch AI, Seoul, South Korea
[2] Korea Adv Inst Sci & Technol, Sch Elect Engn, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
k-Core; Hypergraph; Deletion attack; Core resilience; MAINTENANCE;
D O I
10.1007/s10618-023-00958-0
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Interactions that involve a group of people or objects are omnipresent in practice. Some examples include the list of recipients of an email, the group of co-authors of a publication, and the users participating in online discussion threads. These interactions are modeled as hypergraphs in which each hyperedge is a set of nodes constituting an interaction. In a hypergraph, the k-core is the sub-hypergraph within which the degree of each node is at least k. Investigating the k-core structures is valuable in revealing some properties of the hypergraph, one of which is the network behavior when facing attacks. Networks in practice are often prone to attacks by which the attacker removes a portion of the nodes or hyperedges to weaken some properties of the networks. The resilience of the k-cores is an indicator of the robustness of the network against such attacks. In this work, we investigate the core resilience of real-world hypergraphs against deletion attacks. How robust are the core structures of real-world hypergraphs in these attack scenarios? Given the complexity of a real-world hypergraph, how should we supplement the hypergraph with augmented hyperedges to enhance its core resilience? In light of several empirical observations regarding core resilience, we present a two-step method that preserves and strengthens the core structures of the hypergraphs.
引用
收藏
页码:2438 / 2493
页数:56
相关论文
共 50 条
  • [41] Budesonide/formoterol via the Elpenhaler® device in asthmatic patients: A real-world effectiveness study (The BOREAS Study)
    Bakakos, Petros
    Papakosta, Despoina
    Loukides, Stylianos
    PNEUMON, 2021, 34 (04)
  • [42] Ustekinumab: "Real-world" outcomes and potential predictors of nonresponse in treatment-refractory Crohn's disease
    Hoffmann, Peter
    Krisam, Johannes
    Wehling, Cyrill
    Kloeters-Plachky, Petra
    Leopold, Yvonne
    Belling, Nina
    Gauss, Annika
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (31) : 4481 - 4492
  • [43] Real-world evidence of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Scheme in patients with relapsed / refractory multiple myeloma
    Garcia-Guinon, Antoni
    Charry, Paola Andrea
    Jimenez, Maria
    Sarra, Josep
    Delgado, Izarbe
    de la Torre, Laura Segura
    Santaliestra, Marta
    Garcia-Pintos, Marta
    Gonzalez, Yolanda
    Senin, Alicia
    Motllo, Cristina
    Abella, Eugenia
    Cabezudo, Elena
    Granell, Miquel
    Sancho, Esther
    Herranz, Maria Jose
    Seres, Yasmina
    Gironella, Mercedes
    Soler, Juan Alfons
    Marti-Tutusaus, Josep Maria
    Ben Azaiz, Ran
    de Larrea, Carlos Fernandez
    ANNALS OF HEMATOLOGY, 2025, 104 (02) : 1177 - 1186
  • [44] Real-world prognostic significance of attaining minimal residual disease negativity in newly diagnosed multiple myeloma
    Wang, Jing
    Li, Jing
    Zhang, Run
    Li, Jianyong
    Chen, Lijuan
    Jin, Yuanyuan
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [45] Needle or Drip?-Real-World Comparison of Intravenous to Subcutaneous Infliximab and Vedolizumab in the Management of Inflammatory Bowel Diseases
    Outtier, An
    Ferrante, Marc
    DIGESTIVE DISEASES AND SCIENCES, 2025, 70 (01) : 17 - 18
  • [46] Real-World Experience With Tofacitinib Dose De-Escalation in Patients With Moderate and Severe Ulcerative Colitis
    Yu, Amy
    Ha, Nghiem B.
    Shi, Bingyan
    Cheng, Yao-Wen
    Mahadevan, Uma
    Beck, Kendall R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (12) : 3115 - +
  • [47] Engine Oil Degradation in the Real-World Bus Fleet Test Based on Two Consecutive Operational Intervals
    Golebiowski, Wojciech
    Wolak, Artur
    Sarkan, Branislav
    LUBRICANTS, 2024, 12 (03)
  • [48] How Effective Were Lifestyle Interventions In Real-World Settings That Were Modeled On The Diabetes Prevention Program?
    Ali, Mohammed K.
    Echouffo-Tcheugui, Justin B.
    Williamson, David F.
    HEALTH AFFAIRS, 2012, 31 (01) : 67 - 75
  • [49] Real-world retrospective review of monotherapy following platinum-based chemotherapy for metastatic urothelial cancer
    Uchida, Hideaki
    Obinata, Daisuke
    Takada, Shogo
    Yoshizawa, Tsuyoshi
    Mochida, Junichi
    Yamaguchi, Kenya
    Takahashi, Satoru
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (05)
  • [50] A real-world disproportionality analysis of mesalazine data mining of the public version of FDA adverse event reporting system
    Liu, Mingdi
    Gu, Liting
    Zhang, Yuning
    Zhou, Honglan
    Wang, Yishu
    Xu, Zhi-Xiang
    FRONTIERS IN PHARMACOLOGY, 2024, 15